INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 201530-03-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTORS MEETIndoco Remedies gets final nod from US FDA for Lacosamide tablet
Pharmaceuticals firm Indoco Remedies Ltd on Tuesday said it has received final approval from the US health regulator for its generic Lacosamide tablet indicated for prevention and control of seizures. The approval granted by the US Food & Drug Administration (USFDA) for Lacosamide tablets is for strengths of 50 mg, 100 mg, 150 mg and 200 mg. These are the generic version of Vimpat Tablets of UCB Inc, the company said in a regulatory filing. Indoco Remedies Managing Director Aditi Kare Panandikar said, "The ANDA approval for Lacosamide Tablets on the day of patent expiry, reverberates our enduring commitment to make quality and affordable generic medicines available to more patients in the United States. Our first shipment of Lacosamide tablets has already reached the US". Lacosamide tablets are indicated for the prevention and control of seizures. It is an anticonvulsant/antiepileptic drug, the company said. Citing IQVIA sales data for the period ending January 2022, the company ..INDOCO REMEDIES LTD. - 532612 - Intimation To Shareholders Holding Shares In Physical Mode For Updating Valid PAN, KYC And Nomination Details.
: Intimation To Shareholders Holding Shares In Physical Mode For Updating Valid PAN, KYC And Nomination Details.INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco Remedies receives USFDA approval for Lacosamide TabletsINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors MeetINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors MeetINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors MeetINDOCO REMEDIES LTD. - 532612 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 Incorporation Of A Wholly Owned Subsidiary Company
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015 Incorporation of a Wholly Owned Subsidiary CompanyINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors Meet